CARBOHYDRASE FROM BACILLUS AMYLOLIQUEFACIENS
Bacterially-derived carbohydrase enzyme preparation obtained from Bacillus amyloliquefaciens is affirmed as safe by FDA regulation under 21 CFR 184.1148 and used to catalyze carbohydrate hydrolysis in food processing.
What It Is
Carbohydrase from Bacillus amyloliquefaciens is a food enzyme preparation derived from the fermentation of a nonpathogenic and nontoxigenic strain of the bacterium Bacillus amyloliquefaciens, a closely related species to Bacillus subtilis that has a history of safe use in industrial biotechnology and food enzyme production. The term "carbohydrase" refers broadly to enzymes that catalyze the hydrolysis of glycosidic bonds in carbohydrates, including alpha-amylases and glucanases that act on starch and other polysaccharides to break them down into smaller sugars. Carbohydrase enzyme preparations are typically mixtures of multiple catalytic activities that support the breakdown of complex carbohydrates during food processing. Under the U.S. Food and Drug Administration (FDA) regulations, this ingredient is described in 21 CFR 184.1148 as a "bacterially-derived carbohydrase enzyme preparation" obtained from culture filtrate following fermentation, and it includes components such as alpha-amylase (EC 3.2.1.1) and beta-glucanase (EC 3.2.1.6) that catalyze the hydrolysis of carbohydrate substrates in foods. The preparation does not introduce viable production organisms into food products, as it consists of the isolated enzyme activities rather than the microbial cells themselves. The ingredient may also appear in regulatory inventories under its CAS number, and its nomenclature and classification reflect its microbial enzyme origin and function in food systems. Regulators consider enzyme additives like this carbohydrase as processing aids that perform specific technological functions in food manufacturing.
How It Is Made
Carbohydrase enzyme preparations from Bacillus amyloliquefaciens are produced through controlled fermentation processes using a nonpathogenic, nontoxigenic strain cultured under conditions optimized for enzyme synthesis. In these industrial fermentations, the bacterial cells are grown in a nutrient medium where conditions such as pH, temperature, and oxygen availability are managed to favor the secretion of extracellular carbohydrase enzymes. After a production phase sufficient for the accumulation of the desired enzyme activities in the fermentation broth, the microbial biomass is removed by filtration or centrifugation to yield a culture filtrate enriched in carbohydrase enzymes. This filtrate may be further clarified or concentrated to achieve a consistent enzyme preparation suitable for food processing applications. The resulting preparation is formulated and stabilized so that its catalytic activities remain effective during storage and use in food manufacturing. Specifications for these enzyme preparations are typically referenced to standards such as the monograph on enzyme preparations in the Food Chemicals Codex, which provide guidelines for purity and activity parameters to ensure consistent performance and safety. The fermentation-derived preparation is characterized by its specific enzyme activities rather than representing a defined single protein product, and production controls aim to minimize impurities and ensure consistent quality across batches.
Why It Is Used In Food
Carbohydrase from Bacillus amyloliquefaciens is used in food and beverage production because of its ability to catalyze the hydrolysis of complex carbohydrates into simpler sugars, which supports various technological processes. For example, alpha-amylase activities break down starches during the production of syrups and other carbohydrate ingredients, improving yield and processing efficiency. In brewing and baking, carbohydrase enzymes reduce viscosity and improve fermentable sugar availability, which can enhance fermentation performance and contribute to desired product texture and quality. In grain processing and other starch-rich ingredient applications, these enzymes help convert raw materials into forms that are easier to handle and process. Enzymes like carbohydrase are used with the intention of achieving specific functional outcomes — such as modifying dough behavior, reducing processing times, or increasing extraction efficiencies — rather than contributing nutritional value per se. Their inclusion in food manufacturing is typically justified by a demonstrated technological need and is governed by regulatory frameworks that acknowledge their function as processing aids, allowing their use when they do not compromise consumer safety and are applied within current good manufacturing practice.
Adi Example Calculation
Because a specific numeric acceptable daily intake (ADI) for carbohydrase from Bacillus amyloliquefaciens has not been established by authoritative bodies, a formal calculation illustrating intake relative to an ADI is not provided here. Instead, regulatory evaluations focus on demonstrating that the production organism and enzyme preparation do not pose safety concerns under intended conditions of use, and that manufacturing processes minimize residual amounts of active enzyme in finished foods. In practice, enzyme preparations used in food manufacturing are subjected to processing conditions that reduce activity, so actual dietary exposure to active enzyme is expected to be negligible when foods reach consumers.
Safety And Health Research
Safety evaluations of enzyme preparations such as microbial carbohydrases typically focus on the source organism, production process, and the absence of harmful contaminants rather than on intrinsic toxicology of the purified enzymes. For carbohydrase preparations derived from nonpathogenic strains of Bacillus amyloliquefaciens, regulatory authorities have reviewed evidence related to the pathogenicity of the production organism and the purity of the enzyme preparation. The U.S. FDA listing in 21 CFR 184.1148 reflects an assessment that such preparations are generally recognized as safe when used in accordance with current good manufacturing practice. Food enzyme safety assessments consider potential allergenicity, exposure, and any toxicological data on the enzyme preparation or similar preparations derived from microbial fermentation. In the European context, EFSA evaluates food enzymes on a case-by-case basis to determine whether they raise safety concerns, considering factors such as qualified presumption of safety (QPS) status of the production organism and potential residual total organic solids in final food products. published EFSA opinions on similar Bacillus amyloliquefaciens-derived enzymes such as alpha-amylase indicate that safety concerns are not raised under intended conditions of use, though the potential for respiratory allergenicity cannot be completely excluded based on sequence homology analyses. These evaluations are used as part of the regulatory decision-making process rather than serving as direct health effect claims. Overall, available evidence supports the safe use of carbohydrase enzyme preparations in food processing when produced and applied within established regulatory frameworks and good manufacturing practices.
Regulatory Status Worldwide
In the United States, carbohydrase from Bacillus amyloliquefaciens is specifically recognized in the Code of Federal Regulations at Title 21 CFR 184.1148 as a bacterially-derived carbohydrase enzyme preparation affirmed as generally recognized as safe (GRAS) for use in food when used in accordance with good manufacturing practice, reflecting its established safety record and historical use in food processing. This regulatory listing describes the ingredient as obtained from the fermentation of nonpathogenic and nontoxigenic strains of Bacillus amyloliquefaciens and related species, with defined enzyme activities that catalyze carbohydrate hydrolysis. The FDA specifies that the ingredient meets general and additional requirements for enzyme preparations as incorporated by reference in compendia such as the Food Chemicals Codex. In the European Union, enzyme preparations added to food require a safety evaluation by the European Food Safety Authority (EFSA) and subsequent inclusion on an EU list of authorized food enzymes under Regulation (EC) No 1332/2008, though a comprehensive Union list of all approved food enzymes has not yet been fully established, and the regulatory process remains ongoing for many enzyme preparations. Globally, enzyme additives are subject to diverse regulatory frameworks that similarly require evidence of safety and technological justification for use in foods. Regulatory approaches recognize carbohydrase preparations as processing aids, with conditions of use governed by safety evaluations and adherence to good manufacturing practice.
Taste And Functional Properties
Enzyme preparations such as carbohydrase from Bacillus amyloliquefaciens do not contribute significant flavor or taste themselves, as they are proteins that catalyze biochemical reactions rather than provide sensory attributes. The primary functional properties relate to catalytic efficacy under specific processing conditions: these enzymes act on glycosidic bonds in carbohydrate substrates, facilitating the breakdown of polysaccharides into oligosaccharides and simple sugars. The activity of carbohydrase enzymes is influenced by factors such as temperature, pH, and substrate availability. In general, microbial carbohydrases used in food processing are selected for stability and activity across a range of conditions encountered during manufacturing, such as moderate heat and varying pH environments. Because they are proteins, they may denature and lose activity at high temperatures beyond their optimal range, which food technologists account for when designing processing steps. Carbohydrase preparations are often characterized by assays that quantify their ability to catalyze the conversion of starches and related substrates, and their performance is described in terms of specific activity units rather than sensory descriptors. Their impact on functional properties in food systems is primarily indirect — for example, by modifying the carbohydrate content, resulting in altered viscosity or fermentable sugar profiles — rather than by contributing taste on their own.
Acceptable Daily Intake Explained
For enzyme preparations like carbohydrase from Bacillus amyloliquefaciens, formal acceptable daily intake (ADI) values are not typically established in the same way as for direct nutritive additives because these enzymes act in food processing and are often removed or denatured in final products. Unlike many food additives that have specific numeric ADI values derived from toxicological dose-response data and safety factors, microbial enzyme preparations recognized as GRAS or evaluated by regulatory authorities are considered safe based on demonstrated history of use, production organism safety, and absence of toxicological concerns at levels used in food manufacturing. In regulatory practice, the concept of ADI may not be applied numerically for processing enzymes; instead, safety assessments emphasize good manufacturing practices that ensure minimal residual activity and contaminants in finished foods. This approach acknowledges that enzyme preparations are tools used to achieve specific technological functions, and any dietary exposure that occurs is incidental and generally very low due to inactivation during processing steps such as heating.
Comparison With Similar Additives
Carbohydrase preparations from microbial sources share functional similarities with other carbohydrate-hydrolyzing enzyme additives such as alpha-amylases derived from Bacillus licheniformis or Aspergillus oryzae, which are also used to break down starches in brewing, baking, and syrup production. While the sources and specific catalytic profiles may vary, these enzymes generally catalyze hydrolysis of glycosidic bonds in starch and other polysaccharides, supporting similar technological objectives in food processing. Differences among such enzymes may include optimal activity conditions (pH and temperature) and substrate specificity, which can influence their preferred applications. For instance, an alpha-amylase from one Bacillus species might be chosen for high-temperature starch liquefaction, whereas a glucoamylase might be selected for producing fermentable sugars in syrup production. Despite these differences, the overarching function of enabling carbohydrate conversion is common, and regulatory evaluations consider safety data for each specific enzyme source and preparation rather than assuming universal equivalence.
Common Food Applications Narrative
Carbohydrase enzyme preparations derived from microbial sources such as Bacillus amyloliquefaciens are widely used across a variety of food and beverage processing applications that involve the transformation of starch-rich raw materials. For instance, in the production of cereal-based ingredients and syrups, carbohydrase enzymes assist in breaking down starch into fermentable sugars, which supports further processing into sweeteners and carbohydrate-rich intermediates. In baking applications, these enzyme preparations can improve dough handling and texture by reducing the viscosity of starch-containing batters and improving gas retention, which contributes to consistent crumb structure and volume in baked goods. Brewing operations also take advantage of carbohydrase activities to support the conversion of grain starches into fermentable sugars, which yeast cells then metabolize during fermentation, aiding in alcohol production as well as contributing to specific flavor and body characteristics of the final product. In grain and starch processing industries, these enzymes enhance extractability and reduce processing times, offering efficiencies in manufacturing that support product consistency. Across these and other applications, the use of carbohydrase preparations is focused on enabling technological transformations of carbohydrate-rich ingredients rather than directly contributing flavor or nutritional value to finished foods.
Safety & Regulations
FDA
- Approved: True
- Regulation: 21 CFR 184.1148
EFSA
- Notes: EFSA authorization pending EU list inclusion and specific enzyme evaluation.
JECFA
- Notes: No specific JECFA entry found for this exact preparation in the searchable database.
Comments
Please login to leave a comment.
No comments yet. Be the first to share!